肛交与替诺福韦灌洗顺序影响HIV替代物及灌洗液结直肠分布:DREAM-02
DREAM-02研究纳入5名参与者,比较替诺福韦灌洗在模拟接受性肛交前或后使用时,灌洗液与HIV替代物的结直肠分布及全身渗透性。灌洗液分布两序列无差异;灌洗后行sRAI时HIV替代物多局限于直肠乙状结肠,灌洗前先行sRAI时则扩展至降结肠;给药后20分钟均见早期血浆TFV峰值。
要点
- 灌洗液结直肠分布不因灌洗与sRAI顺序不同而改变。
- 灌洗后行sRAI时HIV替代物多位于直肠乙状结肠,灌洗前先行sRAI时扩展至降结肠。
- 无论顺序,给药后20分钟均观察到早期血浆TFV峰值。
核心结论
- 肛交后灌洗可能增加HIV在结肠的分布,对HIV感染风险的影响尚不确定。
- 早期血浆TFV峰值提示保护起效时间可能比既往研究报告的更短。
研究设计与样本
- 5名参与者完成2次配对研究访视。
- 访视1:先给予111In-DTPA标记的替诺福韦灌洗,再以99mTc-硫胶体自体精液行模拟RAI。
- 访视2:先以放射性标记行模拟RAI,再给予放射性标记的替诺福韦灌洗。
- 采用SPECT/CT评估灌洗液与HIV替代物的结直肠分布,血浆TFV浓度评估全身渗透性。
主要发现
- 灌洗液结直肠分布两序列间无差异。
- 灌洗后行sRAI时,大部分HIV替代物位于直肠乙状结肠;灌洗前先行sRAI时,分布扩展至降结肠。
- 无论顺序,给药后20分钟均观察到早期血浆TFV峰值。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Men who have sex with men are at high risk of human immunodeficiency virus (HIV) acquisition through unprotected receptive anal intercourse (RAI). Behaviorally congruent HIV preexposure prophylaxis (PrEP) has long been advocated by individuals who find adherence challenging or prefer minimizing systemic drug concentrations. We developed an event-driven, behaviorally congruent rectal tenofovir douche as a PrEP option for RAI and demonstrated product safety/acceptability in a previous clinical study. Here, our goal was to compare colorectal distribution of an HIV surrogate and tenofovir douche when the tenofovir douche preceded or followed simulated RAI (sRAI). METHODS: Five participants completed 2 paired study visits. At visit one, participants received an 111indium-diethylenetriaminepentaacetic acid-labelled tenofovir douche prior to sRAI using 99mTc-sulfur colloid in autologous semen as HIV surrogate. At visit two, the radiolabeled tenofovir douche was administered following radiolabeled sRAI. Colorectal distribution of both douche and HIV surrogate radioisotopes were assessed using single-photon emission computed tomography/transmission computed tomography. Systemic permeability was assessed by plasma TFV concentrations. RESULTS: Colorectal distribution of the douche was not different between sequences. Conversely, the majority of HIV surrogate was within the rectosigmoid when the douche was administered prior to sRAI, but the distribution extended into descending colon when the douche was administered following sRAI. Regardless of sequence, an early plasma TFV peak 20 minutes after dosing was observed. CONCLUSIONS: Douching following RAI may increase HIV distribution in the colon with uncertain impact on HIV acquisition risk. The early plasma TFV suggests even more rapid time to protection than reported in prior studies. CLINICAL TRIALS REGISTRATION: NCT04195776.
引用
- Zheng R, Fuchs EJ, Nimmagadda S, et al. Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02. J Infect Dis. 2025. PMID: 40447283. doi:10.1093/infdis/jiaf286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。